KRT8 was positively expressed in head-and-neck squamous cell carcinomas and metastases, but not in hyperplastic leukoplakia, indicating that KRT8 can be used as an attractive marker molecule for differentiating between diagnoses of leukoplakia and head-and-neck carcinomas [22, 23]. The gene discussed is KRT8; the disease is leukoplakia.